Androgen Deprivation Therapy and Cognitive Function in Prostate Cancer
Read MoreExercise makes ADT more manageable – but does it matter when you start exercising?
Timing of exercise for muscle strength and physical function in men initiating ADT for prostate cancer.
Read MoreYet again, ADT and Cognitive Decline: Does the Type of ADT Matter?
Different androgen deprivation therapies might have a differential impact on cognition – An analysis from a population-based study using time-dependent exposure model.
Read MoreWhat’s the latest on a possible link between ADT and the risk of dementia?
Risk of dementia following androgen deprivation therapy for treatment of prostate cancer.
Read MoreAnd here's a paper that fails to find an association between ADT and cognitive impairment
Prostate Cancer, Use of Androgen Deprivation Therapy, and Cognitive Impairment: A Population-based Study.
Read MoreMemory and Mood on ADT
Risk of Dementia and Depression in Young and Middle-aged Men Presenting with Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy.
Read MoreHow Many Men on ADT are Using Cannabis and What Do They Believe about Its Effects?
Prevalence and predictors of cannabis use among men receiving androgen-deprivation therapy for advanced prostate cancer.
Read MoreADT and the Risk of Cardiovascular Disease and Stroke—a Summary of Two Reviews
Androgen Deprivation Therapy and the Risk of Stroke in Patients with Prostate Cancer: An Updated Systematic Review and Meta-Analysis.
Is Androgen Deprivation Therapy for Prostate Cancer Associated with Cardiovascular disease? A Meta-Analysis and systematic review.
Read MoreDo some ADT medications carry greater risk of cardiovascular disease than others?
The risk of cardiovascular disease in prostate cancer patients receiving androgen deprivation therapies.
Read MoreWhat effect does ADT have on PSMA expression by prostate cancer cells?
Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients.
Read More